[Letter: Peripheral blood circulation disorders due to beta receptor blockers?].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000139:chemically induced*; D006801:Humans; D010096:Oxprenolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D011928:Raynaud Disease / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D011433:Propranolol
Periphere Durchblutungsstörungen durch beta-Rezeptorenblocker?